Daniel J Grint

16PUBLICATIONS
86CO-AUTHORS
Innate immunityDisease surveillanceMajor global burdens of diseaseNanomedicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 05, 2026
Imprecision in tuberculosis infection outcomes: implications for non-inferiority vaccine trials.

Daniel J Grint, Richard G White, Gavin Churchyard

|Feb 10, 2026
Treatment Adherence With an Oral 9-Month Regimen for Rifampicin-Resistant Tuberculosis in South Africa.

Johanna Kuhlin, Jacob A M Stadler, Daniel J Grint

|Dec 01, 2025
Epstein-Barr Virus Central Nervous System Infections and Mortality Risk in Patients Presenting With Suspected Meningitis: Results From the Botswana National Meningitis Survey and the Harare Meningitis Aetiology Study.

Jayne Ellis, James Milburn, Kebatshabile Ngoni

|Oct 09, 2025
Intensified Treatment of Tuberculous Meningitis in Adults: A Systematic Review and Meta-analysis.

Andrea Llamas-Lopez, James A Seddon, Felicia C Chow

|Oct 03, 2025
Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA).

Victoria Babirye Tumusiime, Eugene Ruzagira, Claire Norcross

|Sep 24, 2025
Xpert MTB/RIF Cycle Threshold as a Marker of Tuberculosis (TB) Disease Severity: Implications for TB Treatment Stratification.

Daniel J Grint, Jasvir Dhillon, Philip D Butcher

Pageof 3

Frequent Collaborators

4 joint publications

James Milburn

3 joint publications

Fiona V Cresswell

3 joint publications

Anna Schultze

3 joint publications

Rohini Mathur